Tesamorelin
Visceral. Surgical. Final.
- Sizes available
- 2mg · 5mg · 10mg · 20mg
- Lab certificate (COA)
- Arrives with shipment
· Research-grade only · Not for human consumption · 21+ ·
FDA-approved therapy for HIV-associated lipodystrophy (Egrifta). Stimulates endogenous GH release.
Mechanism · GHRH analog (GRF[1-44]). FDA approved 2010. HIV lipodystrophy indication.
Mechanism, dose, ramp, risk.
- Mechanism
- GHRH analogue. Targets visceral adipose tissue with high specificity.Source · PEPVERA editorial
- Target dose
- 2 mg / day for 12 weeks.Source · PEPVERA editorial
- Ramp
- Begin full dose. Subq abdominal nightly.Source · PEPVERA editorial
- Risks
- Allergic reaction in rare accounts. Stop on flare.Source · PEPVERA editorial
Compared to its siblings.
Tesamorelin
FDA-approved therapy for HIV-associated lipodystrophy (Egrifta). Stimulates endogenous GH release.
COA per supplier
Published, in-house, or shipment-time
Each supplier declares its own HPLC floor and COA policy. The per-supplier verifier appears on the certificate page; refund and shipping terms vary by supplier and are shown on the supplier listing.
Compare 10 suppliers
| Supplier | Price | COA | Ships | |
|---|---|---|---|---|
| Pure Peptide UKUK | $24$12.00/mg · 2mg | In-house COA | 4 days | Out of stock |
| SwissChemsUS | $27.95$13.97/mg · 2mg | COA with shipment | 3 days | |
| Orion PeptidesUS | $49.99$10.00/mg · 5mg | COA with shipment | 3 days | Out of stock |
| NG PeptidesUS | $50$5.00/mg · 10mg | Sample COA published | 3 days | Out of stock |
| Ameano PeptidesUS | $68$6.80/mg · 10mg | Sample COA published | 2 days | |
| Royal PeptidesUS | $75$7.50/mg · 10mg | Sample COA published | 3 days | Out of stock |
| Ascension PeptidesUS | $85$17.00/mg · 5mg | Sample COA published | 3 days | Out of stock |
| PeptiraUS | $89$8.90/mg · 10mg | COA with shipment | 3 days | Out of stock |
| NG PeptidesUS | $90$4.50/mg · 20mg | Sample COA published | 3 days | Out of stock |
| Royal PeptidesUS | $120$6.00/mg · 20mg | Sample COA published | 3 days |
Direct from foundry. Slower than domestic resellers; consistency is the trade. Insulated packaging, tracked from departure to doorstep. Replacement issued on damage.
Week 1–2
0.25 mg / wk
Baseline ramp
Week 3–4
0.5 mg / wk
Hold, observe
Week 5–8
1.0–2.0 mg / wk
Ascend
Week 9–12
2 mg / day for 12 weeks.
Terminus
Draw 20 units.
0.2 mg = 0.20 mL at 1.00 mg/mL. 10.0 doses per vial.
cut · V · SwissChems
Tesamorelin · 2mg